📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK non-small cell lung cancer (2024)

First Author: Bayliss R

Attributed to: Understanding and targeting oncogenic biomolecular condensates of ALK kinase funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.21203/rs.3.rs-3919151/v1

Publication URI: http://dx.doi.org/10.21203/rs.3.rs-3919151/v1

Type: Preprint